Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Drug Alcohol Depend. 2015 Mar 19;151:68–75. doi: 10.1016/j.drugalcdep.2015.02.034

Table 3.

Correlates of HCV infection among soon-to-be-released Azerbaijani prisoners (N = 510).

Covariate N (%)a Bivariate analysis
Multivariate analysis
Unadjusted Odds Ratio 95% C.I. p-value Adjusted Odds Ratio 95% C.I. p-value
Male 452 (88.6) 6.23 2.62–14.80 <0.001* 9.78* 2.4–39.7* 0.001*
Female 58 (11.4) Ref Ref
Recidivist 339 (66.5) 1.84 1.27–2.68 0.001* 0.76 0.44–1.31 0.315
First time offender 171 (33.5) Ref Ref
Completed high school 188 (36.9) 0.529 0.82–1.73 0.196
Have worked abroad (in Russia or Ukraine) 64 (12.9) 1.10 0.64–1.87 0.736
Income below poverty line 269 (52.7) 0.881 0.61–1.27 0.493
Major depression 129 (26.0) 2.47 1.75–4.00 <0.001* 2.04* 1.15–3.60* 0.014*
Anxiety disorder 24 (4.8) 2.33 1.02–5.37 0.046* 0.49 0.14–1.69 0.257
Alcohol use disorder 2 (10.2) 4.42 2.35–8.32 <0.001* 3.33* 1.46–7.59* 0.004*
Use in 30 days before incarceration
Any substance use 154 (31.0) 13.91 8.75–22.11 <0.001*
Amphetamine use 2 (0.4) 1.60 0.10–25.75 0.740
Opioid use 151 (30.0) 15.69 9.74–25.26 <0.001*
Sedatives use 13 (2.6) 3.72 1.13–12.26 0.031*
Reused syringe, container or needle 65 (13.1) 26.62 10.44–67.83 <0.001* 4.79* 1.57–14.61* 0.006*
Multiple-substance use 38 (7.5) 0.38 0.19–0.74 0.004*
Lifetime use
Injected drugs 161 (31.9) 20.63 12.68–33.57 <0.001* 12.85* 7.09–23.29* <0.001*
Any substance use 169 (35.7) 16.96 10.61–27.13 <0.001*
Tattoo from non-professional 138 (73.8) 1.97 1.36–2.86 <0.001* 1.33 0.81–2.18 0.264
Akaike Information Criterion (AIC) 436.6
*

Significant difference, defined as p ≤0.05.

a

Percent of those reporting.